Increased [H-3] quisqualic acid binding density in the dorsal striatum and anterior insula of alcoholics : A post-mortem whole-hemisphere autoradiography study by Laukkanen, Virpi et al.
 
Accepted Manuscript
Increased [³H]quisqualic acid binding density in the dorsal striatum
and anterior insula of alcoholics: a post-mortem whole-hemisphere
autoradiography study
Virpi Laukkanen M.D., Ph.D. , Olli Kärkkäinen Ph.D. ,
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 mGluR1/5 binding is increased in the putamen of Cloninger type 1 and 2 alcoholics 
 mGluR1/5 binding is increased in the caudate head of both alcoholic subtypes 
 mGluR1/5 binding is increased also in the anterior insula of both alcoholic subtypes 
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The function of group I metabotropic glutamate receptors mGluR1 and mGluR5 is involved 
in the hyperglutamatergic state caused by chronic alcohol. Preclinical studies suggest that 
group I mGluR modulation could serve as a novel treatment of alcoholism. Considering the 
wide role of glutamatergic neurochemistry in addiction, group I mGluR binding was studied 
in brain areas involved in decision-making, learning and memory. 
Post-mortem whole hemisphere autoradiography was used to study the binding density of 
[³H]quisqualic acid, a potent group I mGluR agonist, in 9 Cloninger type 1 alcoholics, 8 
Cloninger type 2 alcoholics and 10 controls. Binding was studied in the dorsal striatum, 
hippocampus and cortex. 
Alcoholics displayed a trend towards increased [³H]quisqualic acid binding in all brain areas. 
The most robust findings were in the putamen (p = 0.006) and anterior insula (p = 0.005), 
where both alcoholic subtypes displayed increased binding compared to the controls. 
These findings suggest altered group I mGluR function in alcoholic subjects in the dorsal 
striatum, which is involved in habitual learning, and in the anterior insula, which has a pivotal 
role in the perception of bodily sensations. Increased [³H]quisqualic acid binding might 
suggest a beneficial impact of mGluR1/5 modulators in the treatment of alcoholism. 
 





















Chronic alcohol use causes a hyperglutamatergic state, during which the amount of 
extracellular glutamate increases, and the function of the receptors and transporters involved 
in glutamate trafficking is altered (Holmes et al., 2013). Addictive drugs, including alcohol, 
affect glutamatergic synaptic plasticity in several brain regions. Altered glutamatergic state 
contributes to different characteristics of addiction; e.g., craving, devaluation of natural 
reinforcers, withdrawal and relapse (Kalivas and Volkow, 2005; Kauer and Malenka 2007). 
The glutamatergic system has an acknowledged role in the learning process (Anwyl, 2009; 
Galván et al., 2008; Yin and Knowlton 2006) and it has a broad regulatory role in cognitive 
functions (Terbeck et al., 2015). 
 
Metabotropic glutamate receptors (mGluRs) are G-protein coupled receptors that modulate 
neurotransmission at a slower pace than ionotropic glutamatergic receptors. Group I mGluRs 
mGluR1 and mGluR5 mainly appear on postsynaptic structures (Hovelsø et al., 2012). 
Rodent studies identify intense group I mGluR distribution in the limbic areas that are 
essential in addiction; e.g., the hippocampus and dorsal striatum, and show substantial 
distribution in the cerebral cortex (Fotuhi et al., 1993; Martin et al., 1992; Romano et al., 
1995; Shigemoto et al., 1992). 
 
The impact of alcohol on group I mGluR function has been demonstrated in several animal 
studies. Chronic alcohol increases the levels of mGluR1 and mGluR5 proteins in several 
brain areas that are essential for both reward and craving, and also for learning and memory; 
e.g., the nucleus accumbens and dentate gyrus (Cozzoli et al., 2012; Galindo et al., 2004). 
Recent human PET studies have demonstrated alterations in mGluR5 availability in cortical 















Group I mGluR modulators are an important research topic for the treatment of addiction, but 
also for the treatment of several other psychiatric disorders. In rodent studies, mGluR5 
antagonists have attenuated withdrawal symptoms, reduced alcohol-intake and reduced 
reinstatement of alcohol-use. Preclinical and rodent studies suggest also anxiolytic and 
antidepressant effects for group I mGluR antagonists (reviewed by Holmes et al. 2013 and 
Krystal et al., 2010). Regretfully, studies with group I mGluR modulators have demonstrated 
also undesirable side-effects like devaluation of natural rewards and cognitive impairment 
(Holmes et al., 2013). In the light of the vast effect of group I mGluRs on various brain 
functions, the recent results of Phase I clinical trial testing of an mGluR5 negative allosteric 
modulator are promising, as the compound was well-tolerated (Haass-Koffler et al., 2017). 
 
Several studies have demonstrated alcohol’s ability to modulate synaptic plasticity (Kauer 
and Malenka, 2007), which is thought to cause the change from casual to compulsive alcohol 
use (Sjoerds et al., 2013). The diagnostic characteristics of addiction, like compulsive drug 
seeking and drug taking are thought to result from a process where repeated drug use leads to 
the formation of a habit. The function of the dorsal striatum has been suggested to play an 
essential role in this harmful learning process (Everitt and Robbins, 2005). mGluR1 and 
mGluR5 are strongly involved in LTP and LTD (long-term potentiation and long-term 
depression, respectively) in the hippocampus, striatum and neocortex (Galván, 2008; 
Gubellini et al., 2003; Lapointe et al., 2004; Perez et al., 2001; Sarihi et al., 2008). LTP and 
LTD are basic receptor level mechanisms underlying brain plasticity, which in turn is 
considered to be a major mechanism for learning and memory (Cooke and Bliss, 2006). 
Possible alterations in group I mGluR function in the striatal and hippocampal areas might be 















Previously, our research group has reported type-specific changes in the binding density of 
both ionotropic and metabotropic glutamate receptors of Cloninger type 1 and type 2 
alcoholics. We have reported increased AMPA receptor and mGluR2/3 binding density in the 
anterior cingulate cortex and decreased NMDA receptor subunit NR2B binding in the nucleus 
accumbens of Cloninger type 2 alcoholics (Kärkkäinen et al., 2013; Kupila et al., 2015, 
Laukkanen et al., 2015) and increased group I mGluR binding density in the CA2 area of 
hippocampus of Cloninger type 1 alcoholics (Kupila et al., 2013). In Cloninger’s model, 
alcoholics are divided into two subgroups. About 80% of alcoholics are Cloninger type 1 
alcoholics, whose onset age of alcoholism is greater than 25 years. Typically, these people 
are low in novelty seeking, prone to anxiety, social and cautious characters. In contrast, 
Cloninger type 2 alcoholics, composing about 20% of alcoholics, are impulsive, high in 
novelty seeking and often comorbid with an antisocial personality disorder (Cloninger et al., 
1988). The onset age of Cloninger type 2 alcoholism is usually less than 25 years. Group I 
mGluR function is involved in the regulation of stress and anxiety, which are among the main 
characteristics that separate Cloninger alcoholic subgroups. Glutamatergic neurotransmission 
in limbic areas is essential in the formation of anxiety (Riaza Bermudo-Soriano et al., 2012), 
and results of animal research highlight the role of mGluR5-driven signaling in both acute 
and chronic stress (Wagner et al., 2013; Wagner et al., 2015). In humans, mGluR5 
availability in paralimbic and cortical areas associates with novelty seeking (Leurquin-Sterk 
et al., 2016). 
 
Recent in-vivo neuroimaging human studies have investigated mGluR5 availability in 
patients with alcohol use disorder (AUD) (Akkus et al., 2018; Leurquin-Sterk et al., 2018). 














area of Cloninger type 1 alcoholics in a whole-hemisphere post-mortem autoradiography 
(Kupila et al., 2013). This preliminary study covered only the level of the ventral striatum, 
where no other differences in mGluR1/5 binding density were detected. In order to get a more 
complete picture of the possible changes in group I mGluR binding density, we now 
evaluated mGluR1/5 binding density in Cloninger type 1 and 2 alcoholics in brain areas that 
are relevant for habituation and learning, such as the dorsal striatum (Kalivas and Volkow, 
2005), but also cortical areas and the hippocampus. 
 
2. Materials and methods 
2.1 Diagnostics and sample preparation 
The methodology of this study has been described earlier (Kupila et al., 2013; Tupala et al., 
2003). In brief, post-mortem brain left hemispheres (17 alcoholics and 10 controls) were 
obtained during clinical autopsy from the
 
Department of Forensic Medicine, University of 
Oulu, Finland, and two of the non-alcoholic control brains were obtained from the 
Department
 
of Forensic Medicine, University of Eastern Finland, Kuopio, Finland. The 
recovery procedure
 
was essentially the same in both locations. This part of
 
the study was 
approved by the Ethics Committees of the University
 
of Oulu, Finland and the National 
Institute of Medico-legal Affairs in Finland. A post-mortem analysis for drugs, which 
included alcohol, and the normal necropsy protocol were
 
performed. None of the hemispheres 




Medical records on the cause of 















Diagnoses were made by two physicians, independently from each
 
other. Medical records’ 
data were available for all 27 subjects.
 
Mental disorders were coded according to DSM-IV 
criteria (APA, 1994),
 
and alcoholic subjects were further sub-classified as type 1 or 2, 
according to criteria established by Cloninger (1988). The kappa coefficient
 
of diagnostic 
agreement between the diagnoses was 0.9; i.e., one type 2 alcoholic was diagnosed as a type 
1 alcoholic
 





defining these two groups of alcoholic subjects were early onset of 
alcohol abuse (before the age of 25) and documented severe
 
antisocial behavior for the 
Cloninger type 2 alcoholic subjects. Subjects
 
having psychotic disorders or any neurological 
diseases (such as epilepsy),
 
or those taking medication that could affect the CNS (such as 
neuroleptics or antidepressants), were excluded. A history of tobacco smoking,
 
based only on 
medical records, was considered unreliable and was not included in the final criteria. 
 
All 27 subjects were Finns. The study groups consisted
 
of nine type 1 alcoholic subjects 
(seven men and two women;
 
age: mean= 52.7 years, standard deviation (SD)= 12.4; post-
mortem interval (PMI): mean= 11.9 hours,
 
SD= 4.5); eight type 2 alcoholic subjects (all men; 
age: mean= 34.6
 
years, SD= 12.2; PMI: mean= 14.1 hours, SD= 3.4);
 
and 10 non-alcoholic 
control subjects (eight men and two women;
 
age: mean= 53.5 years, SD= 10.7; PMI: mean= 
14.8 hours,
 
SD= 9.2). One of the controls was excluded from the analyses as a statistical 
outlier. None of the controls had a psychiatric diagnosis. There was no statistically significant 
difference in the time between death and autopsy between the three groups (P= 0.62 – 0.98, 
Scheffe’s test for
 
multiple comparisons, two-tailed). Six of the eight type 2 alcoholic subjects 
had a criminal record or a history of violent offences (physical or sexual). Alcoholism in both 














and doctors’ appointments due to alcohol-related problems. Eight of the nine type 1
 
alcoholics had alcohol in their blood at the time of
 
death, and one alcoholic subject had an 
incarcerated abstinence period of
 
10 hours. Two type 1 alcoholic subjects had traces of 
diazepam
 
in their blood samples. Six of the eight type 2 alcoholic subjects had alcohol
 
in their 
blood at the time of death, three had traces of benzodiazepines,
 
and one tested positive for 
cannabinoids, however this may have been a false positive due to the use of ibuprofen, with 
the diagnostic test that was used. One control subject had a
 
small amount of alcohol in his 
blood at the time of death (0.04%).
 
All subjects died of sudden causes. For details of the 
study subjects, see Supplementary Information, Table S1. 
 
Cryosectioning and autoradiography were performed at the Department
 
of Pharmacology and 
Toxicology, University of Eastern Finland, Kuopio, Finland (for detailed methods, see 
Tupala et al., 2003). Individual variations in brain size were considered when selecting 
representative sections. Each cryosection was coded for a subsequent blind analysis of the 
data. 
 
2.2 Group I mGluR binding assay and data analysis 
We used tritium labeled quisqualic acid ([³H]quisqualic acid) in human post-mortem whole 
hemisphere autoradiography. The method of this study was identical to our earlier mGluR1/5 
binding density study (Kupila et al., 2013), and a modification of that reported by Mutel and 
his co-workers (2000), and of our previous experiments with other radioligands for the same 
study subjects (for example, see Laukkanen et al., 2013). Two parallel incubations were 
performed in containers of 2.5 liters, both consisting of one canto-meatal brain slice of each 














HCl buffer, pH 7.4, containing 2mM MgCl2, 2mM CaCl2 (at room temperature). To reach 
equilibrium, one set of 27 sections was incubated for 60 minutes at room temperature in a 
solution containing 3nM of [
3
H]quisqualic acid (Code TRK1070, Batch 24, Specific activity 
= 28.0 Ci/mmol, GE Healthcare UK Ltd. Amersham, UK). Non-specific binding was 
determined by incubating a set of 27 adjacent sections with 10µM glutamate as a displacer. 
Both incubations contained 30µM kainate to inhibit [³H]quisqualic acid binding to ionotropic 
glutamate receptors. In the method paper of Mutel and colleagues (2000), the Kd values of 
[
3
H]quisqualic acid were reported to be 27 and 81 nM for mGluR1 and mGluR5, 
respectively. Cryosections were washed in a cold buffer for 3 x 1 min, followed by a brief dip 
into ice-cold distilled water. Thereafter, sections were dried under a gentle stream of warm air 
for 10 minutes and then left for 5 days at room temperature before exposure to phosphor 
imaging plates (BAS IP-TR 2040, Fuji Photo Film, Co., LTD, Japan) for 14 days, and 
subsequently scanned (Storm 860 PhosphorImager scanner, Amersham, Little Chalfont, UK). 
The autoradiograms were analyzed using phosphor imager analysis (Image J, National 
Institutes of Health, USA), and the resulting luminescent values of the binding data were 
converted to pmol/mg by the use of 
3
H-calibrating scales (cat. no. RPA 507, Amersham, 
Little Chalfont, UK). The non-specific binding was subtracted from the total binding to yield 
specific binding. All analyses were made blind to the clinical classification of the sample. 
 
In all, twelve brain areas from the canto-meatally oriented level of the dorsal striatum were 
selected for the analysis; i.e., the anterior cingulate cortex, the anterior prefrontal cortex, the 
medial prefrontal cortex, the lateral prefrontal cortex, the posterior cingulate cortex, the 
hippocampus, the dentate gyrus, the anterior insula and the posterior insula, the head of the 















2.3 Statistical analyses  
Results are expressed as the mean with SD. Due to the small sample size, the data was 
unsuitable for straightforward statistical analyses. The statistical significance between groups 
was evaluated by a bootstrap type analysis of co-variance (ANCOVA, 5000 replications) 
with appropriate contrast (Efron and Tibshirani, 1998), using age as a covariate. A bootstrap-
based multiplicity adjustment was applied to correct the levels of significance for multiple 
testing. Possible correlations between [3H]quisqualic acid binding and age, PMI and blood 
alcohol content (BAC) were determined by a two-tailed Pearson’s correlation coefficient. P-
values of less than 0.05 were considered to be statistically significant for all tests. STATA 





H]quisqualic acid binding to brain areas can be observed in Figure 1, and the results of 
selective [
3
H]quisqualic acid binding are presented in Table 1. Both alcoholic subtypes 
displayed increased binding in all of the 12 measured brain areas when compared to controls. 
There was a statistically significant difference in [³H]quisqualic acid binding density between 
three study groups in the dorsal striatum, in the putamen (p = 0.006) and in the caudate head 
(p = 0.041), where both Cloninger type 1 and type 2 alcoholics displayed significantly 
increased binding density when compared to controls. There also was a statistically 
significant difference in [
3
H]quisqualic acid binding between the groups in the anterior insula 
(p = 0.005), where both alcoholic subgroups displayed significantly increased [
3
H]quisqualic 
acid binding. In the hippocampus, [³H]quisqualic acid binding between the study groups 
differed significantly (p = 0.029), and the increase in binding density of Cloninger type 2 



















The main finding of this study is a statistically significant increase in [³H]quisqualic acid 
binding density, indicating increased mGluR1/5 binding, in the putamen, caudate head and 
anterior insula of Cloninger type 1 and Cloninger type 2 alcoholics. A statistically significant 
increase in mGluR1/5 binding was detected in the hippocampus of Cloninger type 2 
alcoholics (See Figure 2). There was a global trend of increased binding density in both 
alcoholic subgroups (See Table 1). The main limitation of our study is the small number of 
study subjects. Therefore, these results should be considered as preliminary, and need to be 
confirmed by future studies. 
 
4.1 A trend of increased mGluR1/5 binding density in alcoholics 
Human and animal in-vivo imaging studies have reported alcohol-induced alterations in 
mGluR5 availability, but the results are partly conflicting. A recent human PET study 
reported increased mGluR5 availability in the temporal lobe, but not in the basal ganglia 
(Akkus et al., 2018), whereas another study (Leurquin-Sterk et al., 2018) found decreased 
mGluR5 availability in the limbic region of abstinent alcoholics. A rodent PET study 
suggested increased mGluR5 availability in cortical and hippocampal areas right after alcohol 
dosing (Nandi et al., 2016). Taken together, the results of imaging studies highlight the 
dynamic effect of alcohol on synaptic plasticity and receptor expression. In our post-mortem 
autoradiography study, we found a trend of increased mGluR1/5 binding density in Cloninger 
type 1 and type 2 alcoholics. Due to the methodological differences and patient selection, our 
results cannot be compared with the findings of in-vivo imaging studies. However, our 















4.2 Increased mGluR1/5 binding in the dorsal striatum of alcoholics 
We found a significant increase in [³H]quisqualic acid binding in the putamen and caudate 
head of both alcoholic subgroups when compared to the controls. The human caudate is 
connected to the associative cortices and the hippocampus, and thus involved in goal-directed 
learning, whereas the putamen connects to the sensorimotor cortices, as an area of habitual 
learning (Yin and Knowlton, 2006). A human fMRI study of Tricomi and co-workers (2009) 
found strengthening BOLD (blood oxygen level dependent) activation of the posterior 
putamen during habit formation, and animal and human studies report activation of the dorsal 
striatum in chronic substance abuse (Porrino et al., 2004; Sjoerds et al., 2013). mGluR5 and 
mGluR1 are vital parts of LTP and LTD of the striatum and corticostriatal connections 
enabling brain plasticity required in a learning process (Anwyl, 2009; Cooke and Bliss, 2006; 
Gubellini et al., 2003). The increased mGluR1/5 binding observed in our study may affect 
LTP and LTD processes of the dorsal striatum and be linked to maladaptive habit learning in 
alcoholics.  
 
4.3 Increased mGluR1/5 binding in the anterior insula of alcoholics 
We found a statistically significant difference in [³H]quisqualic acid binding density between 
the groups in the anterior insula. The increase in binding was statistically significant in 
Cloninger type 1 and 2 alcoholics. 
 
The insular cortex is broadly connected to several cortical and subcortical areas (Augustine, 
1996; Wisner et al., 2013). The anterior insula is activated in effortful cognitive processing 
and cognitive perception of bodily states, and the intensity of urge in addiction correlates 
with activation of the insula (Craig, 2002; Naqvi and Bechara 2010; Paulus and Stewart, 














several other brain areas in addiction, and in a PET study, mGluR5 availability of the insula 
correlated positively with the mGluR5 availability in the other cortical regions in AUD 
patients, but not in the controls (Akkus et al., 2018; Claus et al., 2013; McHugh et al., 2013; 
Wisner et al., 2013). The increased mGluR1/5 binding in the anterior insula of alcoholics 
observed in our study might affect the cognitive interpretation of bodily states, which has 
been linked to addiction (Naqvi and Bechara, 2010).  
 
4.4 Increased mGluR1/5 binding in the hippocampus of Cloninger type 2 alcoholics 
In the hippocampus, Cloninger type 2 alcoholics displayed a statistically significant increase 
in [³H]quisqualic acid binding density when compared to controls. This finding needs 
confirmation of further studies, for we had to exclude 2 controls and 2 type 1 alcoholics from 
the analysis of hippocampus due to anatomical and technical problems. In addition, the 
heterogeneity among type 1 alcoholics was wide. Recent rodent studies suggest alcohol-
induced alterations in hippocampal mGluR5 expression, which seem to progress during 
different states of intoxication and withdrawal (de Laat 2018 et al., Marszalek-Grabska et al. 
2018). Our findings of altered mGluR1/5 binding in the hippocampus of Cloninger type 2 
alcoholics is in line with these studies, suggesting altered group I mGluR function of this area 
in alcoholism.  
 
4.5. A comprehensive interpretation of our mGluR1/5 study results 
In our previous study about [³H]quisqualic acid binding density on the level of ventral 
striatum, we found increased mGluR1/5 binding density in the CA2 area of hippocampus in 
Cloninger type 1 alcoholics, and no further differences between the groups were detected 
(Kupila et al., 2013). In that study, one area of the ventral striatum was defined as nucleus 














remnants of the fused caudate and putamen were also quantitated, even though such division 
may not be anatomically justified, and these anatomical terms should be used only on the 
level of the dorsal striatum (Neto et al., 2008). In order to get a more complete picture of the 
possible alterations in mGluR1/5 binding in Cloninger type 1 and 2 alcoholics, we now 
analyzed [³H]quisqualic acid binding in the level of dorsal striatum, and detected increased 
mGluR1/5 binding in both alcoholic subgroups in the putamen, head of caudate and anterior 
insula of both alcoholic subgroups. In addition, we observed increased mGluR1/5 binding in 
the hippocampus of Cloninger type 2 alcoholics. In the current study, we did not divide 
hippocampus to the subregions of CA1, CA2 and CA3. This approach was chosen, for the 
anatomical areas of these subregions are small and their borders partly difficult to define. In 
our previous study, binding densities of CA1 and CA2 were highly similar and correlated in 
all study groups, and in the controls, binding of all three subregions correlated positively. 
Even though the hippocampus was analyzed as a whole, we had to exclude 4 subjects from 
the analysis due to technical difficulties. Therefore, the findings of this area need to be 
interpreted with caution. 
 
It has been suggested, that during different stages of addiction, different parts of the striatum 
are activated. There is a gradual shift in activity from the ventral to the dorsal striatum during 
the addictive process. At the same time, goal-oriented action, which is sensitive to the 
variable cues of the environment, is taken over by habitual automatic behavior. This, in turn, 
is characteristic to addiction and other binge-type repetitive behaviors seen in many 
psychiatric and neurologic conditions (Graybiel, 2008). Before their death, the alcoholism of 
our alcoholic study subjects was severe and, in most cases, it had endured for years. 
Together, the findings of our previous (Kupila et al., 2013) and this study may suggest altered 














when compared to controls. Our study method can’t distinguish, whether this alteration in 
mGluR1/5 binding density preceded alcoholism, or is a consequence of the repetitive 
behavior, the prolonged severe alcohol use.  
 
5. Conclusions 
In conclusion, we used post-mortem human whole hemisphere autoradiography to study 
[³H]quisqualic acid binding density in Cloninger type 1 and 2 alcoholics and controls. The 
most robust, statistically significant increase in binding density was detected in the dorsal 
striatum and anterior insula of both alcoholic subgroups. The increase in mGluR1/5 binding 
in the putamen and caudate head might link to the tendency of a habituated response among 
alcoholics, which maintains addictive behavior and predisposes to relapse. The increased 
mGluR1/5 binding in the anterior insula might affect the function of this area, like cognitive 
processing of bodily states and urges, which links to withdrawal and relapse propensity. 
These findings suggest that group I mGluRs may be a useful target for pharmacological 
therapy of alcoholism. 
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Table 1. Selective and specific [
3
H]quisqualic acid binding density to mGluR1/5 in controls, 
Cloninger type 1 and Cloninger type 2 alcoholics in twelve brain areas on the canto-meatally 
oriented level of the dorsal striatum.  
 









aPFC 5.23 (0.92) 6.48 (2.45) 6.48 (2.45) 0.22 
mPFC 4.96 (1.09) 5.83 (2.17) 7.07 (3.20) 0.13 
lPFC 6.68 (2.24) 10.88 (7.19) 9.69 (4.87) 0.10 
ACC 6.25 (1.37) 7.06 (2.01) 8.07 (4.40) 0.29 
aINS 7.48 (1.98) 11.17 (4.61)* 11.18 (5.01)* 0.005 
pINS 7.92 (1.84) 11.18 (5.44) 11.88 (6.17) 0.053 
Putamen 3.00 (0.77) 4.38 (1.80)* 4.23 (1.69)* 0.006 
Head of Caudate 4.23 (1.03) 5.67 (2.04)* 5.49 (2.37)* 0.041 
GP 0.75 (0.55) 1.32 (0.91) 0.86 (0.72) 0.089 
Hippo 8.55 (2.29) 13.83 (7.18) 12.74 (4.24)* 0.029 
DG 7.60 (2.01) 8.25 (3.61) 9.21 (2.82) 0.17 





Legends: Mean stated as the mean binding density (pmol/mg) of [
3
H]quisqualic acid; SD, 
standard deviation; ACC, anterior cingulate cortex; aINS, anterior insula; aPFC, anterior 
prefrontal cortex; DG, dentate gyrus; GP, globus pallidus; Hippo, hippocampus; lPFC, lateral 
prefrontal cortex; mPFC, medial prefrontal cortex; PCC, posterior cingulate cortex; pINS, 
posterior insula; *, statistically significant difference when compared to controls (bootstrap 
type analysis of co-variance, 5000 replications, using age as covariate, with a bootstrap-based 



















Figure 1. The whole brain hemisphere autoradiograms of the canto-meatally oriented brain 
slices on the level of the dorsal striatum, demonstrating A) the selective binding of 
[³H]quisqualic acid without a displacer, and B) [³H]quisqualic acid binding with gluatamate 
as a displacer. Legends: ACC, anterior cingulate cortex; aINS, anterior insula; aPFC, anterior 
prefrontal cortex; DG, dentate gyrus; GP, globus pallidus; HCau, caudate head; Hippo, 
hippocampus; lPFC, lateral prefrontal cortex; mPFC, medial prefrontal cortex; PCC posterior 















Figure 2. Selective and specific [³H]quisqualic acid binding to mGluR1/5 in controls, 
Cloninger type 1 and Cloninger type 2 alcoholics. The binding density was significantly 
different between three groups both in the putamen (p = 0.006), head of caudate (p = 0.041), 
anterior insula (p = 0.005) and hippocampus (p = 0.029) by using bootstrap-type analysis of 
covariance, 5000 replications, using age as covariate. Both alcoholic subgroups displayed a 
statistically significant binding increase when compared to the controls in the putamen, head 














Cloninger type 2 alcoholics was statistically significant. A greater heterogeneity among 
alcoholic subjects than controls can be observed. 
